DK1131104T3 - Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester - Google Patents

Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester

Info

Publication number
DK1131104T3
DK1131104T3 DK99972109T DK99972109T DK1131104T3 DK 1131104 T3 DK1131104 T3 DK 1131104T3 DK 99972109 T DK99972109 T DK 99972109T DK 99972109 T DK99972109 T DK 99972109T DK 1131104 T3 DK1131104 T3 DK 1131104T3
Authority
DK
Denmark
Prior art keywords
propylene glycol
acid ester
alkanoic acid
antiviral formulations
isopropyl alkanoic
Prior art date
Application number
DK99972109T
Other languages
Danish (da)
English (en)
Inventor
Gunilla Lekare
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20413320&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1131104(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of DK1131104T3 publication Critical patent/DK1131104T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK99972109T 1998-11-18 1999-11-12 Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester DK1131104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9803929A SE9803929D0 (sv) 1998-11-18 1998-11-18 Antiviral formulation
PCT/SE1999/002043 WO2000029027A1 (en) 1998-11-18 1999-11-12 Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester

Publications (1)

Publication Number Publication Date
DK1131104T3 true DK1131104T3 (da) 2005-03-14

Family

ID=20413320

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99972109T DK1131104T3 (da) 1998-11-18 1999-11-12 Antivirale formuleringer, der omfatter propylenglycol og en isopropyl-alkansyreester

Country Status (21)

Country Link
EP (1) EP1131104B1 (ko)
JP (2) JP2002529520A (ko)
KR (1) KR100608963B1 (ko)
CN (1) CN1160128C (ko)
AR (1) AR023705A1 (ko)
AT (1) ATE288283T1 (ko)
AU (1) AU772435B2 (ko)
CA (1) CA2351463C (ko)
DE (1) DE69923584T2 (ko)
DK (1) DK1131104T3 (ko)
EG (1) EG23853A (ko)
ES (1) ES2233104T3 (ko)
HK (1) HK1042440B (ko)
IL (2) IL142702A0 (ko)
MY (1) MY122397A (ko)
NZ (1) NZ511832A (ko)
PT (1) PT1131104E (ko)
SE (1) SE9803929D0 (ko)
TW (1) TW589191B (ko)
WO (1) WO2000029027A1 (ko)
ZA (1) ZA200103335B (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04004532A (es) 2001-11-19 2004-08-11 Medigene Ag Medicamento para el tratamiento de enfermedades tumorales y virales de la piel.
WO2005037300A1 (en) 2003-10-09 2005-04-28 Medigene Ag The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438585B (en) * 1995-02-06 2001-06-07 Astra Ab Pharmaceutical compositions for topical administration for prophylaxis and/or treatment of herpesvirus infections
US5760096A (en) * 1996-10-18 1998-06-02 Thornfeldt; Carl R. Potent penetration enhancers

Also Published As

Publication number Publication date
TW589191B (en) 2004-06-01
DE69923584D1 (de) 2005-03-10
MY122397A (en) 2006-04-29
HK1042440A1 (en) 2002-08-16
IL142702A (en) 2006-07-05
KR20010075720A (ko) 2001-08-09
EP1131104B1 (en) 2005-02-02
ZA200103335B (en) 2002-07-24
HK1042440B (zh) 2005-04-29
AU772435B2 (en) 2004-04-29
EP1131104A1 (en) 2001-09-12
CN1160128C (zh) 2004-08-04
ATE288283T1 (de) 2005-02-15
AU1436400A (en) 2000-06-05
JP2011157392A (ja) 2011-08-18
NZ511832A (en) 2003-09-26
IL142702A0 (en) 2002-03-10
AR023705A1 (es) 2002-09-04
CN1326364A (zh) 2001-12-12
SE9803929D0 (sv) 1998-11-18
ES2233104T3 (es) 2005-06-01
DE69923584T2 (de) 2006-03-23
CA2351463C (en) 2009-10-13
JP5420583B2 (ja) 2014-02-19
WO2000029027A1 (en) 2000-05-25
EG23853A (en) 2007-11-06
PT1131104E (pt) 2005-03-31
JP2002529520A (ja) 2002-09-10
KR100608963B1 (ko) 2006-08-09
CA2351463A1 (en) 2000-05-25

Similar Documents

Publication Publication Date Title
DE69907435D1 (de) (4-sulfonylamino)-tetrahydropyran-4-carbonsäure hydroxamiden
IS5555A (is) Selekoxib lyfjablöndur
ID30031A (id) Formulasi-formulasi agrokimia
ID23546A (id) Formulasi-formulasi ziprasidon
DE69942880D1 (de) Hochfrequenzverstärker
NO20004240D0 (no) Formuleringer
DE69703385D1 (de) Alkoxyessigsäure-derivate
NO990821D0 (no) Arylsulfonylamino-hydroksaminsyre-derivater
DE60036776D1 (de) Verstärkerschaltung
ATE224703T1 (de) Brauseformulierungen
DE69907548D1 (de) Hochfrequenzleistungsverstärker
EE04772B1 (et) 3-arüül-2-hüdroksüpropaanhappe derivaat (I)
ATE248812T1 (de) Arylsulfonylhydroxamsäurederivate
DK1003720T3 (da) Aryloxyarylsulfonylaminohydroxamsyrederivater
DE69820392D1 (de) Hochfrequenzschaltung
PT1130966E (pt) Formulacoes antiparasitarias
NO2009010I2 (no) Metoksypolyenglykol-epoetin beta beta
ID23299A (id) Formulasi-formulasi farmasi
DE69918278D1 (de) Substituierte indolalkansäure
DE69813049D1 (de) Hochfrequenzleistungsverstärker
MA24473A1 (fr) Formulations
DK1100769T3 (da) Aminomethylcarboxylsyrederivater
NO20020151D0 (no) Veksthormonformuleringer
ID29489A (id) Produksi monoetilene glikol pemurnian tinggi
ID27975A (id) Peralatan penjepit gulungan